Matching Biomarkers to Disease Biology & Therapy
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Ramesh Bulusu, Dr. John Glod & Dr. Jason Sicklick discussed GIST research updates and answered questions in this GIST Awareness Day 2023 presentation.
The LRG Medical Advisory Board issued a statement in response to a NEJM article on telemedicine with the hope that other organizations & physicians will follow suit, advocating for treatment ease & equity.
In this interview with researcher & surgical oncologist Dr. Jason Sicklick shares about his passion for SDH-deficient GIST research.
Our Good News Holiday Campaign is the culmination of our year of "Time to Tell the Stories 2022." In this series, we celebrate the connections, the celebrations, the events and milestones that we’ve been privileged to be a part of this year. Dr. Jason Sicklick discusses his research in SDH-deficient GIST.
Dr. Jason SIcklick, UC San Diego Moores Cancer Center presented The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy at Life Fest 2022 in New Orleans.
The Life Raft Group Data Management & Research and Communications Team attended remotely to gain knowledge of current research in GIST and to track breaking news and social media networking. In this post, we present commentary on several presentations and posters.
Dr. Jason Sicklick of Moores Cancer Center at UC San Diego dedicated his new research lab to the memory of GISTer Merak Melikian Hatounian.
Two new studies were published in July and August 2021 focusing on SDH-deficient tumor models and how location can affect GIST tumor profiles and drug sensitivity.
The LRG will be collaborating with the NIH again in 2021 to hold the Virtual GIST Tumor Board in place of the NIH's Pediatric & Wildtype GIST Clinic normally held in the DC area. Applications to have cases reviewed are now open.